News
Warner Chappell signs Bob Sinclar, while Sheer Publishing Africa rebrands as Downtown Music Publishing Africa.
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
Shareholders of Eli Lilly (Symbol: LLY) looking to boost their income beyond the stock's 0.8% annualized dividend yield can sell the June 2027 covered call at the $1000 strike and collect the ...
Two former Eli Lilly executives and their families will donate $20 million to IU Health Foundation — the largest philanthropic gift in the foundation's history — to establish the Institute for ...
"This solution is really focused towards clients that aren't covering it today, and what it allows us to do is one, to bring it on at a reduced price for the plan sponsor, but also capping out the ...
Lilly Holmes singled twice and scored for Newark ... two runs and an RBI and Zane Hancock a run and two RBIs for the Panthers (18-6). Tino Martin doubled twice and singled for Licking Heights ...
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from US rival Eli Lilly, makes inroads into its market share and as its pipeline of new ...
The pharmaceutical giant has been racing against rivals such as Eli Lilly to dominate the highly lucrative weight-loss space. Morgan Stanley Research is projecting that the global market for ...
Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...
Novo Nordisk A/S is replacing Chief Executive Officer Lars Fruergaard Jorgensen as the drugmaker wrestles with increased competition for its Wegovy obesity shots that transformed the weight-loss ...
Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on treating hearing loss. The centerpiece of the agreement is ...
Eli Lilly has spent the last several years reintroducing itself to the public via a series of corporate campaigns. Its latest push continues that effort but also goes a step further, inviting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results